Cited by 208Vaccine Coverage and HesitancyImmune responses and vaccinationsIntramuscular injections and effects

The DOI matches its Crossref record; 110 of the 116 references it cites were found in a registry or an index.

Vaccination of special populations: Protecting the vulnerable

Open access

Doherty, Mark, Schmidt-Ott, Ruprecht, Santos, Jose Ignacio, Stanberry, Lawrence R., Hofstetter, Annika M., Rosenthal, Susan L., Cunningham, Anthony L.·2016·Vaccine

DOI 10.1016/j.vaccine.2016.11.015

Open this paper in CoChat — free account Open PDF

Abstract

One of the strategic objectives of the 2011-2020 Global Vaccine Action Plan is for the benefits of immunisation to be equitably extended to all people. This approach encompasses special groups at increased risk of vaccine-preventable diseases, such as preterm infants and pregnant women, as well as those with chronic and immune-compromising medical conditions or at increased risk of disease due to immunosenescence. Despite demonstrations of effectiveness and safety, vaccine uptake in these special groups is frequently lower than expected, even in developed countries with vaccination strategies in place. For example, uptake of the influenza vaccine in pregnancy rarely exceeds 50% in developed countries and, although data are scarce, it appears that only half of preterm infants are up-to-date with routine paediatric vaccinations. Many people with chronic medical conditions or who are immunocompromised due to disease or aging are also under-vaccinated. In the US, coverage among people aged 65years or older was 67% for the influenza vaccine in the 2014-2015 season and 55-60% for tetanus and pneumococcal vaccines in 2013, while the coverage rate for herpes zoster vaccination among those aged 60years or older was only 24%. In most other countries, rates are far lower. Reasons for under-vaccination of special groups include fear of adverse outcomes or illness caused by the vaccine, the inconvenience (and in some settings, cost) of vaccination and lack of awareness of the need for vaccination or national recommendations. There is also evidence that healthcare providers' attitudes towards vaccination are among the most important influences on the decision to vaccinate. It is clear that physicians' adherence to recommendations needs to be improved, particularly where patients receive care from multiple subspecialists and receive little or no care from primary care providers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2016.11.015

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Cohn, A. C., MacNeil, J. R., Clark, T. A., Ortega‐Sanchez, I. R., Briere, E. Z., Meissner, H. C., Baker, C. J., & Messonnier, N. E. (2013) · PEDIATRICS · doi:10.1542/peds.2013-2511 · Cited by 1,845
General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Kroger, A. T., ATKINSON, W. L., Marcuse, E. K., & Pickering, L. K. (1994) · PsycEXTRA Dataset · doi:10.1037/e546992006-001 · Cited by 1,712
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501184 · Cited by 1,454
Self-citation
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
Bonten, M. J. M., Huijts, S. M., Bolkenbaas, M., Webber, C., Patterson, S., Gault, S., van Werkhoven, C. H., van Deursen, A. M. M., Sanders, E. A. M., Verheij, T. J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408544 · Cited by 1,248
Effectiveness of maternal influenza immunization in mothers and infants
Zaman, K., Roy, E., Arifeen, S. E., Rahman, M., Raqib, R., Wilson, E., Omer, S. B., Shahid, N. S., Breiman, R. F., & Steinhoff, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708630 · Cited by 1,227
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070
Self-citation
Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P. T., Davies, E. G., Avery, R. K., Tomblyn, M. R., Bousvaros, A., Dhanireddy, S., Sung, L., KEYSERLING, H. L., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit816 · Cited by 1,039
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand
The ANZIC Influenza Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908481 · Cited by 1,002

Show all 116 references

Sorted by citations

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Arunachalam, P. S., Walls, A. C., Golden, N., Atyeo, C. G., Fischinger, S., Li, C., Aye, P. P., Navarro, M. J., Lai, L., Edara, V. V., et al. (2021) · Nature · doi:10.1038/s41586-021-03530-2 · Cited by 317
What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis.
Truong, J., Bakshi, S., Wasim, A., Ahmad, M., & Majid, U. (2021) · Health Promotion International · doi:10.1093/heapro/daab105 · Cited by 180
Vaccine strategies: Optimising outcomes
Hardt, K., Bonanni, P., King, S., Santos, J. I., El-Hodhod, M. A.-A., Zimet, G. D., & Preiss, S. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.078 · Cited by 144
Self-citation
Who and when to vaccinate against influenza
Buchy, P., & Badur, S. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.040 · Cited by 114
Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2
Gale, E. C., Powell, A. E., Roth, G. A., Meany, E. L., Yan, J., Ou, B. S., Grosskopf, A. K., Adamska, J. Z., Picece, V. C. T. M., d’Aquino, A. I., et al. (2021) · Advanced Materials · doi:10.1002/adma.202104362 · Cited by 107
Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies
Restivo, V., Costantino, C., Bono, S. E., Maniglia, M., Marchese, V., Ventura, G., Casuccio, A., Tramuto, F., & Vitale, F. M. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1321722 · Cited by 92
CD 4 T cells in protection from influenza virus: Viral antigen specificity and functional potential
Sant, A. J., DiPiazza, A. T., Nayak, J. L., Rattan, A., & Richards, K. A. (2018) · Immunological Reviews · doi:10.1111/imr.12662 · Cited by 89
Challenges in adult vaccination
de Gomensoro, E., Giudice, G. D., & Doherty, T. M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1417632 · Cited by 85
Key steps in vaccine development
Stern, P. L. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.01.025 · Cited by 80
Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups
Boey, L., Bosmans, E., Ferreira, L. B., Heyvaert, N., Nelen, M., Smans, L., Tuerlinckx, H., Roelants, M., Claes, K. J., Derdelinckx, I., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1763739 · Cited by 71
The role of health determinants in the influenza vaccination uptake among older adults (65+): a scope review
Roller‐Wirnsberger, R., Lindner, S., Kolosovski, L., Platzer, E., Dovjak, P., Flick, H., Tziraki, C., & Illario, M. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01793-3 · Cited by 70
Life-course immunization as a gateway to health
Philip, R. K., Attwell, K., Breuer, T., Pasquale, A. D., & Lopalco, P. L. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1527690 · Cited by 57
SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges
Cooper, D. M., Afghani, B., Byington, C. L., Cunningham, C. K., Golub, S., Lu, K. D., Radom-Aizik, S., Ross, L. F., Singh, J., Smoyer, W. E., et al. (2021) · Pediatric Research · doi:10.1038/s41390-021-01402-z · Cited by 55
Vaccine uptake and barriers to vaccination among at-risk adult populations in the US
Kolobova, I., Nyaku, M. K., Karakusevic, A., Bridge, D., Fotheringham, I., & O’Brien, M. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2055422 · Cited by 55
Immunization of preterm infants with GSK’s hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity
Omeñaca, F., Vázquez, L., Garcı́a-Corbeira, P., Mesaros, N. E., Hanssens, L., Dolhain, J., Gómez, I. P., Liese, J. G., & Knuf, M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.005 · Cited by 49
Leaving no one behind: Defining and implementing an integrated life course approach to vaccination across the next decade as part of the immunization Agenda 2030
Wallace, A. S., Ryman, T. K., Privor-Dumm, L. A., Morgan, C., Fields, R., Garcia, C., Sodha, S. V., Lindstrand, A., & Lochlainn, L. N. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.11.039 · Cited by 43
Influenza vaccine uptake among older adults in Brazil: Socioeconomic equality and the role of preventive policies and public services
Sato, A. P. S., Antunes, J. L. F., Lima‐Costa, M. F., & de Andrade, F. B. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.07.022 · Cited by 39
Observational study of vaccination in cancer patients: How can vaccine coverage be improved?
Monier, A., Puyade, M., Hernanz, M. P. G., Bouchaert, P., Leleu, X. P., Tourani, J. M., Roblot, F., & Rammaert, B. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.11.006 · Cited by 38
Vaccination coverage in patients affected by chronic diseases: A 2014 cross-sectional study among subjects hospitalized at Bari Policlinico General Hospital
Gallone, M. S., Infantino, V., Ferorelli, D., Stefanizzi, P., Nitto, S. D., & Tafuri, S. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.10.004 · Cited by 36
Vaccinations and Chronic Diseases: Knowledge, Attitudes, and Self-Reported Adherence among Patients in Italy
Napolitano, F., Polla, G. D., Capano, M. S., Augimeri, M., & Angelillo, I. F. (2020) · Vaccines · doi:10.3390/vaccines8040560 · Cited by 36
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
Hodel, K. V. S., Fiuza, B. S. D., Conceição, R. S., Aleluia, A. C. M., Pitanga, T. N., Fonseca, L. M. D. S., Valente, C. O., Rezende, C. S. M. E., & Machado, B. A. S. (2024) · Pharmaceuticals · doi:10.3390/ph17060807 · Cited by 38
Patient’s behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient’s influenza vaccine uptake
Casalino, E., Ghazali, D. A., Bouzid, D., Antoniol, S., Pereira, L., Kenway, P., & Choquet, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193029 · Cited by 35
Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana
Yamoah, P., Bangalee, V., & Oosthuizen, F. (2019) · Vaccines · doi:10.3390/vaccines7010028 · Cited by 35
OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines
Cotugno, N., Ruggiero, A., Santilli, V., Manno, E. C., Rocca, S., Zicari, S., Amodio, D., Colucci, M., Rossi, P., Levy, O., et al. (2019) · Journal of Immunology Research · doi:10.1155/2019/8732191 · Cited by 39
Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations
Wang, Y., Li, J., Wang, Y., Gu, W., & Zhu, F. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1409316 · Cited by 35
Vaccination of immune compromised children—an overview for physicians
Pittet, L. F., & Posfay-Barbe, K. M. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-03997-1 · Cited by 31
How Immunocompromised Hosts Were Left Behind in the Quest to Control the COVID-19 Pandemic
Boeckh, M., Pergam, S. A., Limaye, A. P., Englund, J. A., Corey, L., & Hill, J. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae308 · Cited by 30
Safety assessment of immunization in pregnancy
Kochhar, S., Bauwens, J., & Bonhoeffer, J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.033 · Cited by 30
Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis
Bianchi, F. P., Stefanizzi, P., Spinelli, G., Mascipinto, S., & Tafuri, S. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1886085 · Cited by 30
Vaccines for healthcare-associated infections: present, future, and expectations
Gagneux‐Brunon, A., Lucht, F., Launay, O., Berthelot, P., & Botelho-Nevers, É. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1470507 · Cited by 28
COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity
Jeong, S., Heo, Y., Jeong, J.-H., Ham, S.-J., Yum, J. S., Ahn, B.-C., Song, C., & Chun, E. (2021) · Vaccines · doi:10.3390/vaccines9090957 · Cited by 29
Knowledge, attitudes, and behavior of incarcerated people regarding COVID-19 and related vaccination: a survey in Italy
Giuseppe, G. D., Pelullo, C. P., Lanzano, R., Napolitano, F., & Pavía, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-04919-3 · Cited by 28
Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study
Falsey, A. R., Hosman, T., Bastian, A. R., Vandenberghe, S., Chan, E. K. H., Douoguih, M., Heijnen, E., Comeaux, C. A., Callendret, B., Allaw, M. B., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00226-3 · Cited by 28
Individual care versus broader public health: A qualitative study of hospital doctors' antibiotic decisions
Broom, J. K., Broom, A. F., Kirby, E. R., Gibson, A. F., & Post, J. J. (2017) · Infection Disease & Health · doi:10.1016/j.idh.2017.05.003 · Cited by 27
Relationship between vaccine hesitancy and vaccination behaviors: Systematic review and meta-analysis of observational studies
Yang, X., Shi, N., Liu, C., Zhang, J., Miao, R., & Jin, H. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.11.051 · Cited by 26
Update on vaccination of preterm infants: a systematic review about safety and efficacy/effectiveness. Proposal for a position statement by Italian Society of Pediatric Allergology and Immunology jointly with the Italian Society of Neonatology.
Chiappini, E., Petrolini, C., Sandini, E., Licari, A., Pugni, L., Mosca, F., & Marseglia, G. L. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1604230 · Cited by 25
Synthesis and Anti-Influenza Virus Effects of Novel Substituted Polycyclic Pyridone Derivatives Modified from Baloxavir
Tang, L., Yan, H., Wu, W., Chen, D., Gao, Z., Hou, J., Zhang, C., & Jiang, Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00979 · Cited by 24
Knowledge, attitudes, beliefs and barriers of healthcare professionals and adults ≥ 65 years about vaccine-preventable diseases in Spain: the ADult Vaccination drIverS and barriErs (ADVISE) study
Margüello, E. R., Trilla, A., Munguira, I. L. B., Jaramillo, A., & Cotarelo, M. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2025007 · Cited by 27
Results from a mobile outreach influenza vaccination program for vulnerable and high‐risk populations in a high‐income setting: lessons learned
Giles, M., Hickman, J., Lingam, V., & Buttery, J. P. (2018) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12810 · Cited by 23
Vaccination timeliness and completeness among preterm and low birthweight infants: a national cohort study
Bary-Weisberg, D., & Stein‐Zamir, C. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1840255 · Cited by 23
National recommendations for adult pneumococcal vaccination in countries of the WHO regions of Americas, Africa, Eastern Mediterranean, South East Asia, and Western Pacific
Fletcher, M. A., Vojicic, J., Daigle, D., Taysi, B. N., Haridy, H., Abalos, M. G., & Morales, G. D. C. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126390 · Cited by 21
Vaccination Coverage among Immunocompromised Patients in a Large Health Maintenance Organization: Findings from a Novel Computerized Registry
David, S. S. B., Goren, I., Mourad, V., & Cahan, A. (2022) · Vaccines · doi:10.3390/vaccines10101654 · Cited by 22
The crucial role of maternal care providers as vaccinators for pregnant women
Vilca, L. M., & Esposito, S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.017 · Cited by 23
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
Pedrazzoli, P., Lasagna, A., Cassaniti, I., Piralla, A., Squeri, A., Bruno, R., Sacchi, P., Baldanti, F., Maïo, M. D., Beretta, G. D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101215 · Cited by 24
An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo
Aliprandini, E., Takata, D. Y., Lepique, A. P., Kalil, J. E., Boscardin, S. B., & Moro, A. M. (2019) · Toxicon X · doi:10.1016/j.toxcx.2019.100006 · Cited by 21
Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases
Esteban-Vasallo, M. D., Domínguez‐Berjón, M. F., García‐Riolobos, C., Zoni, A. C., Torres, J. L. A., Perruca, L. S., & Astray‐Mochales, J. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.062 · Cited by 21
In-hospital and web-based intervention to counteract vaccine hesitancy in very preterm infants’ families: a NICU experience
Mauro, A. D., Mauro, F. D., Greco, C. N., Giannico, O. V., Grosso, F. M., Baldassarre, M. E., Capozza, M., SCHETTINI, F., Stefanizzi, P., & Laforgia, N. (2021) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-021-01129-x · Cited by 19
Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity
Chan, M., Ahmadi, A., Yao, S., Sato-Kaneko, F., Messer, K. S., Pu, M., Nguyen, B., Hayashi, T., Corr, M., Carson, D. A., et al. (2017) · ACS Combinatorial Science · doi:10.1021/acscombsci.7b00080 · Cited by 21
The Value of Rotavirus Vaccination in Europe: A Call for Action
Cohen, R., Martinón‐Torres, F., Posiuniene, I., Benninghoff, B., Oh, K.-B., & Poelaert, D. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00697-7 · Cited by 18
Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping review
Chadi, A., Thirion, D. J. G., & David, P. (2023) · BMC Public Health · doi:10.1186/s12889-023-16601-y · Cited by 20
Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients
Boey, L., Bosmans, E., Ferreira, L. B., Heyvaert, N., Nelen, M., Smans, L., Tuerlinckx, H., Roelants, M., Claes, K. J., Derdelinckx, I., et al. (2021) · Vaccines · doi:10.3390/vaccines9010018 · Cited by 17
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?
Cotugno, N., Pighi, C., Rocchi, F., Ruggiero, A., Amodio, D., Medri, C., Colagrossi, L., Russo, C., Cesare, S. D., Santilli, V., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003999 · Cited by 17
Current and emerging Mpox vaccine strategies: A comprehensive review
Ortiz‐Prado, E., Kyriakidis, N. C., López‐Cortés, A., Vásconez-González, J., Suarez, I., Pazmiño-Almeida, J. C., Barriga-Collantes, M. A., Cadena, M. P., Reascos-Arteaga, M., Acosta-Muñoz, E., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127598 · Cited by 16
Five Year Follow Up of Extremely Low Gestational Age Infants after Timely or Delayed Administration of Routine Vaccinations
Fortmann, M. I., Dammann, M.-T., Humberg, A., Siller, B., Stichtenoth, G., Engels, G., Marißen, J., Faust, K., Hanke, K., Goedicke‐Fritz, S., et al. (2021) · Vaccines · doi:10.3390/vaccines9050493 · Cited by 16
Vaccines and Immunization
Pettigrew, Z. J., Kim, M. H., & Becker‐Dreps, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-29171-5_12 · Cited by 18
Association between race/ethnicity and disability status and receipt of vaccines among older adults in Florida
Khan, S. R., Hall, A. G., Tanner, R., & Marlow, N. M. (2017) · Disability and health journal · doi:10.1016/j.dhjo.2017.11.004 · Cited by 16
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology
Lasagna, A., Brunello, A., Silvestris, N., Pedrazzoli, P., Maïo, M. D., & Cinieri, S. (2023) · Tumori Journal · doi:10.1177/03008916231191547 · Cited by 15
Fighting flu: novel CD8+ T‐cell targets are required for future influenza vaccines
Leong, S. L., Gras, S., & Grant, E. J. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1491 · Cited by 15
Impact of Recommended Maternal Vaccination Programs on the Clinical Presentation of SARS-CoV-2 Infection: A Prospective Observational Study
de la Cruz, M. L., Pardilla, M. B. E., Sánchez, M. G., Rodríguez, L. G., Muner, M., Royuela, A., Recarte, P. P., Martínez‐Varea, A., Martínez‐Diago, C., Melguizo, S. C., et al. (2021) · Vaccines · doi:10.3390/vaccines9010031 · Cited by 15
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesPreprint
Arunachalam, P. S., Walls, A. C., Golden, N., Atyeo, C. G., Fischinger, S., Li, C., Aye, P. P., Navarro, M. J., Lai, L., Edara, V. V., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.10.430696 · Cited by 15
Capturing the value of vaccination: impact of vaccine-preventable disease on hospitalization
Doherty, M. T., Aris, E., Servotte, N., & Beck, E. C. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02110-2 · Cited by 14
Self-citation
Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations
Andreoni, M., Sticchi, L., Nozza, S., Sarmati, L., Gori, A., Tavio, M., & Society for Infectious and Tropical Diseases (SIMIT) (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1971473 · Cited by 14
Midwives’ experiences of discussing health behaviour change within routine maternity care: A qualitative systematic review and meta-synthesis
Talbot, H., Peters, S., Furber, C., & Smith, D. M. (2024) · Women and Birth · doi:10.1016/j.wombi.2024.01.002 · Cited by 15
Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review
Walker, E. J. L., MacDonald, N. E., Islam, N., Saux, N. L., Top, K. A., & Fell, D. B. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.02.031 · Cited by 13
COVID-19 vaccination in pregnancy: ambiguity in decision-making
Jones, E., & Neely, E. (2023) · Health Promotion International · doi:10.1093/heapro/daad144 · Cited by 13
Innovation in active and passive immunisation of people who are immunocompromised: a call to action
Hill, J. A., Boonyaratanakornkit, J. B., Mikulska, M., Teh, B. W., Hahn, W. O., Haidar, G., Liu, C., Kumar, D., Ison, M. G., & Halasa, N. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00345-7 · Cited by 12
Reasons of the delayed vaccination, recommendations and safety of vaccination in children with congenital heart disease in Zhejiang, China
Li, M., Ji, C., Zeng, Y., Yao, D., Wang, X., & Shao, J. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1872343 · Cited by 12
Impact of a dedicated post-transplant vaccination service at an Australian cancer centre
Teh, B. W., Joyce, T., Slavin, M. A., Thursky, K., & Worth, L. J. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.195 · Cited by 12
Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort
Rollet-Cohen, V., Mirete, J. O., Dingulu, G., Hofer, F., Hofer, M., Woerner, A., Dommergues, M., & Hentgen, V. (2021) · Clinical Rheumatology · doi:10.1007/s10067-020-05553-y · Cited by 12
Establishing a Dialogue with a Patient on Vaccination (Scientific Review)
Ермоленко, К. Д., Михайловна, Х. С., Александровна, Р. А., & Drozdova, L. Y. (2021) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2021-20-1-114-124 · Cited by 12
A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations
Bonanni, P., Ceddia, F., & Dawson, R. S. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad150 · Cited by 11
Resumen ejecutivo del documento de actualización y reflexión sobre vacunación antigripal en España
García, A., Fernández-Prada, M., Arı́stegui, J., Moreno, D., Redondo, E., Jimeno, I., Cenoz, M. G., & Trigo, J. A. L. (2018) · Vacunas · doi:10.1016/j.vacun.2018.10.001 · Cited by 11
Vaccination coverage and immunization safety among children with special health status in Chongqing, China
Xu, B., Zhang, Y., Zhou, C., Wang, Q., & Luan, R. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2138466 · Cited by 11
Understanding influenza vaccination among Portuguese elderly: the social ecological framework
Machado, A., Santos, A. J., Kislaya, I., Larrauri, A., & Nunes, B. (2020) · Health Promotion International · doi:10.1093/heapro/daaa011 · Cited by 11
Revision Total Hip Arthroplasty in Solid Organ Transplant Patients: A Propensity Score-Matched Cohort Study for Aseptic and Infected Revisions
Upfill-Brown, A., Hart, C. M., Hsiue, P. P., Burgess, K., Chen, C. J., Khoshbin, A., Photopoulos, C. D., & Stavrakis, A. I. (2022) · Arthroplasty Today · doi:10.1016/j.artd.2021.10.007 · Cited by 10
Baited vaccines: A strategy to mitigate rodent‐borne viral zoonoses in humans
Mendoza, E. J., Warner, B. M., Kobinger, G., Ogden, N. H., & Safronetz, D. (2018) · Zoonoses and Public Health · doi:10.1111/zph.12487 · Cited by 10
AGE, AUTOIMMUNITY, AND INFLAMMATION: THE CURIOUS CASE OF IMMUNOSENESCENCE AND INFLAMM-AGING
Sundaram, T. G., & Ahmed, S. (2022) · Anti-Aging Eastern Europe · doi:10.56543/aaeeu.2022.1.1.04 · Cited by 10
Estimation of vaccination coverage and associated factors in older Mexican adults
Hernández, H. G., Zárate-Ramírez, J., Kammar‐García, A., & García‐Peña, C. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823001218 · Cited by 9
The influence of the COVID-19 pandemic on patients with chronic inflammatory demyelinating polyradiculoneuropathy
Stojanov, A., Božović, I., Stojanov, J., Palibrk, A., Djordjević, G., Basta, I. Z., Malobabić, M., Arsić, A. A., & Perić, S. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106654 · Cited by 9
A cGAMP-containing hydrogel for prolonged SARS-CoV-2 RBD subunit vaccine exposure induces a broad and potent humoral responsePreprint
Böhnert, V., Gale, E. C., Lahey, L., Yan, J., Powell, A. E., Ou, B. S., Carozza, J., Li, L.-Y., & Appel, E. (2021) · bioRxiv · doi:10.1101/2021.07.03.451025 · Cited by 5
A 5-year look-back at the notification and management of vaccine supply shortages in Germany
Miranda-García, M. A., Hoffelner, M., Stoll, H., Ruhaltinger, D., Cichutek, K., Siedler, A., & Bekeredjian‐Ding, I. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.17.2100167 · Cited by 8
Trained Immunity-Based Vaccines: A Ready-to-Act Strategy to Tackle Viral Outbreaks
Conejero, L., Saz-Leal, P., & Subiza, J. L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.95765 · Cited by 9
Lowering the recommended age for the free and active offer of influenza vaccination in Italy: clinical and economic impact analysis in the Liguria region
Trucchi, C., D’Amelio, M., Amicizia, D., Orsi, A., Loiacono, I., Tosatto, R., Piazza, M. F., Paganino, C., Pitrelli, A., Icardi, G., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1810494 · Cited by 8
Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies
Sullivan, K. E., Bassiri, H., Bousfiha, A. A., Costa‐Carvalho, B. T., Freeman, A. F., Hagin, D., Lau, Y., Lionakis, M. S., Moreira, I., Pinto, J. A., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0426-2 · Cited by 9
Factors Associated with Influenza Vaccination Among Urban Community-Dwelling Chinese Elderly: Results from a Multicity Cross-Sectional Study
Guo, J., Jiao, X., Yuan, S., & You, L. (2025) · Vaccines · doi:10.3390/vaccines13111171 · Cited by 7
Childhood immunization coverage during the COVID-19 Pandemic in the Province of Siracusa, Italy
Contarino, F. M., Pietro, E. D., Bella, F., Randazzo, C., & Contrino, M. L. (2022) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2022.63.4.2587 · Cited by 9
Delayed Start of Routine Vaccination in Preterm and Small-for-Gestational-Age Infants: An Area-Based Cohort Study from the Tuscany Region, Italy
Lastrucci, V., Puglia, M., Pacifici, M., Buscemi, P., Sica, M., Alderotti, G., Belli, G., Berti, E., Rusconi, F., & Voller, F. (2022) · Vaccines · doi:10.3390/vaccines10091414 · Cited by 7
Are younger COPD patients adequately vaccinated for influenza and pneumococcus?
Gogou, E., Hatzoglou, C., Zarogiannis, S. G., Siachpazidou, D. S., Gerogianni, I., Kotsiou, O. S., Varsamas, C., & Gourgoulianis, K. I. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106988 · Cited by 7
Early vs Deferred Non–Messenger RNA COVID-19 Vaccination Among Chinese Patients With a History of Inactive Uveitis
Zhong, Z., Wu, Q., Lai, Y., Dai, L., Gao, Y., Liao, W., Su, G., Wang, Y., Zhou, C., & Yang, P. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.55804 · Cited by 7
Pediatric Resident Attitudes Toward Inpatient Immunization of Children and Adolescents: Highlighting Differences in Human Papillomavirus Vaccination
Pfaff, N., Garnett, C. A., Mihalek, A. J., Mamey, M. R., & Wu, S. Y. (2019) · Global Pediatric Health · doi:10.1177/2333794x19894123 · Cited by 7
Strategies to Increase Vaccinations in Adult Cancer Patients: A Systematic Review
Moro, G. L., Golzio, F., Calabrese, S. C., Scaioli, G., Basile, A., Siliquini, R., & Bert, F. (2025) · Vaccines · doi:10.3390/vaccines13090964 · Cited by 6
Camel Milk as a Functional Food: Nutritional Composition, Health‐Promoting Benefits, and Safety Considerations
Bereda, G., Uthirapathy, S., & Ahamad, J. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71638 · Cited by 6
Prevention of chronic diseases in middle-age women: a cross-sectional study on an Italian large sample
Colombo, A. I. M., Voglino, G., Sessa, A., Bert, F., Maestroni, A. M., Moro, G. L., Caielli, R., Siliquini, R., & Rosa, M. C. D. (2019) · European Journal of Public Health · doi:10.1093/eurpub/ckz121 · Cited by 6
Psychological Determinants of Vaccination Readiness against COVID-19 and Seasonal Influenza of the Chronically Ill in Primary Care in Germany—A Cross-Sectional Survey
Sanftenberg, L., Keppeler, S., Heithorst, N., Dreischulte, T., Roos, M., Sckopke, P., Bühner, M., & Gensichen, J. S. (2023) · Vaccines · doi:10.3390/vaccines11121795 · Cited by 6
Knowledge, attitudes, barriers and uptake rate of influenza virus vaccine among children from 6 months to 5 years of age in Jordan: a multicentric cross-sectional study
Abu-Helalah, M. A., Abdelhadi, N. N., Al‐Hanaktah, M., Asfour, A., Harahsheh, M. M., Mahfouz, R. A., Altarawneh, S., Almadani, M., & Mughrabi, L. A. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-01935-7 · Cited by 6
Longitudinal Pathways to Influenza Vaccination Vary With Socio-Structural Disadvantages
Farkhad, B. F., Karan, A., & Albarracín, D. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab087 · Cited by 7
Revision total knee arthroplasty outcomes in solid organ transplant Patients, a matched cohort study of aseptic and infected revisions
Upfill-Brown, A., Wu, S. Y., Hart, C., Hsiue, P. P., Chen, C. J., Ponzio, D., Photopoulos, C., & Stavrakis, A. I. (2022) · The Knee · doi:10.1016/j.knee.2021.12.007 · Cited by 6
Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice
Du, Y., Zhang, S., Zhang, Z., Miah, K. M., Wei, P., Zhang, L., Zhu, Y., Li, Z., Ye, F., Gill, D. R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.819058 · Cited by 6
Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses
Katoto, P. D., Kakubu, M. A., Tamuzi, J. L., Brand, A., Ayuk, A. C., Byamungu, L. N., Wiysonge, C. S., & Gray, G. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2204154 · Cited by 6
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective
Vaid, A. K., Rastogi, N., Doherty, T. M., Martin, P. F. M. S., & Chugh, Y. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2224186 · Cited by 6

Authors: Doherty, M., Schmidt-Ott, R., Santos, J. I., Stanberry, L. R., Hofstetter, A. M., Rosenthal, S. L., & Cunningham, A. L.
Affiliations: GlaxoSmithKline (Belgium) (BE)
Morgan Stanley Children's Hospital (US)
University of Washington (US)
Columbia University Irving Medical Center (US)
Westmead Institute (AU)
Corresponding author: Doherty, Mark
ORCID: Doherty, Mark
Stanberry, Lawrence R.
Hofstetter, Annika M.
Rosenthal, Susan L.
Cunningham, Anthony L.
Venue: Vaccine
Publisher: Elsevier BV
Published: 2016-12
Volume: 34
Issue: 52
Pages: 6681-6690
ISSN: 0264-410X (ISSN-L)
DOI: 10.1016/j.vaccine.2016.11.015
OpenAlex: W2549658434
Cited by: 208
References: 116
Citations by year: 2026: 15 · 2025: 25 · 2024: 23 · 2023: 25 · 2022: 24 · 2021: 36 · 2020: 14 · 2019: 13 · 2018: 15 · 2017: 16 · 2016: 2
FWCI: 2.92
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Vaccine (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: Merck
Topics: Social Sciences › Health › Vaccine Coverage and Hesitancy
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
Keywords: vaccine uptake, preterm infants, pregnant women, influenza vaccination, chronic disease, immunocompromised patients, immunosenescence, older adults, vaccine hesitancy, clinician attitudes, Global Vaccine Action Plan, vaccination coverage
MeSH terms: Humans, Vaccination, Global Health, Disease Transmission, Infectious, Vulnerable Populations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vaccination of special populations: Protecting the vulnerable

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks